We are live on
!
Find out more
JPC
Jackson Park Capital Portfolio holdings
AUM
$53.7M
1-Year Est. Return
6.17%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+6.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$73M
AUM Growth
-$4.55M
(-5.9%)
Cap. Flow
-$2.98M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
43.69%
Holding
54
New
13
Increased
6
Reduced
16
Closed
12
Avg Time Held
2.6
quarters
Top 10 Avg Time Held
2.3
quarters
Top 20 Avg Time Held
2.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.08M |
| 2 |
Goldman Sachs
GS
|
+$2.65M |
| 3 |
Marriott International
MAR
|
+$2.21M |
| 4 |
Robert Half
RHI
|
+$1.96M |
| 5 |
ProShares Short S&P500
SH
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$2.4M |
| 2 |
STJ
St Jude Medical
STJ
|
+$2.09M |
| 3 |
Capital One
COF
|
+$1.74M |
| 4 |
Royal Bank of Canada
RY
|
+$1.73M |
| 5 |
JPMorgan Chase
JPM
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.66% |
| 2 | Healthcare | 15.71% |
| 3 | Consumer Discretionary | 12.07% |
| 4 | Communication Services | 9.35% |
| 5 | Energy | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NLSN
26
DELISTED
Nielsen Holdings plc
NLSN
| $1.3M | 1.78% |
25,000
-8,000
| -24% | -$422K |
2014 Q4
6 quarters
|
|
27
NOV
NOV
$6.76B
| $1.25M | 1.71% |
+37,000
| New | +$1.19M |
2016 Q2
0 quarters
|
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $1.18M | 1.62% |
+12,000
| New | +$1.24M |
2016 Q2
0 quarters
|
|
29
TransDigm Group
TDG
$61.5B
| $1.05M | 1.45% |
4,000
-1,000
| -20% | -$244K |
2016 Q1
1 quarter
|
|
|
TIF
30
DELISTED
Tiffany & Co.
TIF
| $1.03M | 1.41% |
17,000
| – | – |
2015 Q1
5 quarters
|
|
31
Aramark
ARMK
$14.4B
| $1M | 1.37% |
41,550
-18,005
| -30% | -$433K |
2014 Q4
6 quarters
|
|
32
T. Rowe Price
TROW
$21.6B
| $949K | 1.3% |
+13,000
| New | +$968K |
2016 Q2
0 quarters
|
|
33
American Express
AXP
$209B
| $851K | 1.17% |
14,000
-1,000
| -7% | -$63.3K |
2014 Q4
6 quarters
|
|
34
Jazz Pharmaceuticals
JAZZ
$13.7B
| $848K | 1.16% |
6,000
| – | – |
2016 Q1
1 quarter
|
|
35
Expedia Group
EXPE
$32.8B
| $797K | 1.09% |
7,500
+500
| +7% | +$54.3K |
2016 Q1
1 quarter
|
|
36
Ametek
AME
$57.4B
| $624K | 0.86% |
13,500
+4,500
| +50% | +$216K |
2016 Q1
1 quarter
|
|
37
Bausch Health
BHC
$2.2B
| $423K | 0.58% |
+21,000
| New | +$595K |
2016 Q2
0 quarters
|
|
38
ProShares Short Russell2000
RWM
$142M
| $295K | 0.4% |
+5,000
| New | +$303K |
2016 Q2
0 quarters
|
|
|
KIN
39
DELISTED
Kindred Biosciences, Inc.
KIN
| $273K | 0.37% |
77,000
| – | – |
2014 Q4
6 quarters
|
|
|
FMI
40
DELISTED
Foundation Medicine, Inc.
FMI
| $233K | 0.32% |
12,500
| – | – |
2016 Q1
1 quarter
|
|
|
NBRV
41
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $195K | 0.27% |
+104
| New | +$210K |
2016 Q2
0 quarters
|
|
42
aTyr Pharma
ATYR
$19.7M
| $183K | 0.25% |
+4,714
| New | +$219K |
2016 Q2
0 quarters
|
|
43
Jacobs Solutions
J
$16.6B
| – | – |
-24,179
| Closed | -$871K | – |
|
44
MSC Industrial Direct
MSM
$7.38B
| – | – |
-7,000
| Closed | -$534K | – |
|
45
Outfront Media
OUT
$5.33B
| – | – |
-21,335
| Closed | -$443K | – |
|
46
PayPal
PYPL
$48.1B
| – | – |
-22,000
| Closed | -$849K | – |
|
|
47
Royal Bank of Canada
RY
$270B
| – | – |
-30,000
| Closed | -$1.73M | – |
|
48
Union Pacific
UNP
$168B
| – | – |
-11,000
| Closed | -$875K | – |
|
|
MON
49
DELISTED
Monsanto Co
MON
| – | – |
-10,000
| Closed | -$877K | – |
|
|
STJ
50
DELISTED
St Jude Medical
STJ
| – | – |
-38,000
| Closed | -$2.09M | – |
|
Similar funds
FNYS
OL
NAM
BC
IWC
RCI
PCM
GCP
Jackson Park Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Jackson Park Capital held 54 positions worth $73M, down 5.9% from $77.5M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jackson Park Capital withdrew a net $2.98M in Q2 2016, closing 12 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $2.09M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jackson Park Capital opened a new position in Biogen worth $2.83M.
- Jackson Park Capital's largest Q2 2016 buy was Biogen: 11,700 shares worth $2.83M.
- Jackson Park Capital added most to Alphabet (Google) Class C in Q2 2016, an estimated $646K increase.
- Jackson Park Capital's biggest Q2 2016 reduction was Yahoo Inc, cutting an estimated $2.4M.
- Jackson Park Capital fully exited St Jude Medical in Q2 2016, selling an estimated $2.09M.
- Jackson Park Capital's ten largest holdings make up 44% of its $73M portfolio in Q2 2016.
- Jackson Park Capital opened 13 new positions and closed 12 in Q2 2016.
- Jackson Park Capital's portfolio value fell 5.9% quarter-over-quarter to $73M.
Based on Jackson Park Capital's 13F filing for Q2 2016, filed 28 Jul 2016.